EPO Patents = 1

Forward Citations = 0

Loading Chart...

5 inventors (with patents filed for the assignee):

Jianxin Duan (2 out of 2 patents)

Anrong Li (2 out of 2 patents)

Zhaoqiang Lu (1 out of 2 patents)

4. Yanjun Zhang (1 out of 2 patents)

5. Fanying Meng (1 out of 9 patents)

6. Xiaohong Cai (1 out of 1 patent)

7. Qunhui Huang (1 out of 1 patent)

8. Jinwei Fan (1 out of 1 patent)

9. Weisu Chen (1 out of 1 patent)

3 patents: Sort by Forward Citations

1. 12723031 - Preparation process of 1-n-methyl-2-nitro-5-hydroxymethyl imidazole (2026-09-01),

2. 12697306 - Orally administered solid dosage form drug (2026-08-04),

3. 12595275 - Fluorine-containing compound and anti-cancer medical use thereof (2026-04-07),

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#1,431 in Shenzhen

#8,337 in China

Shenzhen, China

Ascentawits Pharmaceuticals, Ltd.

Forward Citations = 0

5 inventors:

Jianxin Duan (2 out of 2 patents)

Anrong Li (2 out of 2 patents)

Zhaoqiang Lu (1 out of 2 patents)

4. Yanjun Zhang (1 out of 2 patents)

5. Fanying Meng (1 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ascentawits Pharmaceuticals, Ltd.. Retrieved from https://idiyas.com/company/ascentawits-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]